NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank80
3Y CAGR-63.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-63.2%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 6.80% |
| 2024 | -12.28% |
| 2023 | -1424.13% |
| 2022 | 136.14% |
| 2021 | -301.92% |
| 2020 | 0.00% |